By Kalwinder Kaur
Quantum International has been making efforts to promote commercial availability of products based on robotic innovation. This budding robotics company has been investigating novel opportunities to reduce the development timeline for certain outstanding advances in robotics.
Last week, The Wall Street Journal announced a new partnership between the scientists at Massachusetts General Hospital, Brown, the Department of Veterans Affairs, the German Aerospace Center and Harvard Medical School, through which two paralyzed patients were intellectually guided to reach for objects using robotic arm. This major advancement is intended to restore physical function to paralyzed individuals and is yet to be commercially available.
One of the major objectives of Quantum International is to reduce the development period between laboratory innovations to product commercialization. QUAN is capable enough to bring the ideas and patents developed in university labs to new, independent enterprises.
QUAN CEO Robert Federowicz says that the effort is to bring the already-existing technology to the marketplace. Fresh innovators and research groups with new innovations readily available for commercialization have been targeted by QUAN. In addition, joint ventures and other deals will enable the company to provide grants or secure financing for products that can create revolution in the 21st Century in medical field. Quantum International can therefore provide dynamic robotics innovations to those markets that are in need.
QUAN anticipates declaring its initial business targets in the red-hot robotics space.